We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This page contains an overview of the Psychoactive Substances Act and supporting documents.
The National Treatment Agency for Substance Misuse (NTA) was established in 2001 to improve the availability, capacity and effectiveness of drug treatment. It became part of Public Health England in 2013.
Explains planning controls relating to the storage of hazardous substances in England and how to handle development proposals around hazardous establishments.
Register as a manufacturer, importer or distributor of active substances for use in veterinary medicines.
The penalties if you are caught taking or dealing drugs - drug classification, fines and prison sentences
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Customer declaration of specific uses of the scheduled category 1 or 2 substances (individual transactions).
Requesting comments on draft Stockholm Convention proposals for 3 chemical substances.
Register as a manufacturer, importer or distributor of active substances.
Groups of ODS with their ozone-depleting potential.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
Brief interventions are short programmes that aim to help reduce or stop substance use
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
Application for a licence to trade in precursor chemicals category 2 substances
The MHRA is continuing to accept Active Substance Master Files (ASMFs) and Certificates of Suitability (CEPs)
Licence and registration application information for companies that deal in precursor chemicals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).